Economic evaluation studies in the field of HIV/AIDS: bibliometric analysis on research development and scopes (GAPRESEARCH)

Abstract

BackgroundThe rapid decrease in international funding for HIV/AIDS has been challenging for many nations to effectively mobilize and allocate their limited resources for HIV/AIDS programs. Economic evaluations can help inform decisions and strategic planning. This study aims to examine the trends and patterns in economic evaluation studies in the field of HIV/AIDS and determine their research landscapes.MethodsUsing the Web of Science databases, we synthesized the number of papers and citations on HIV/AIDS and economic evaluation from 1990 to 2017. Collaborations between authors and countries, networks of keywords and research topics were visualized using frequency of co-occurrence and Jaccards’ similarity index. A Latent Dirichlet Allocation (LDA) analysis to categorize papers into different topics/themes.ResultsA total of 372 economic evaluation papers were selected, including 351 cost-effectiveness analyses (CEA), 11 cost-utility analyses (CUA), 12 cost-benefit analyses (CBA). The growth of publications, their citations and usages have increased remarkably over the years. Major research topics in economic evaluation studies consisted of antiretroviral therapy (ART) initiation and treatment; drug use prevention interventions and prevention of mother-to-child transmission interventions. Moreover, lack of contextualized evidence was found in specific settings with high burden HIV epidemics, as well as emerging most-at-risk populations such as trans-genders or migrants.ConclusionThis study highlights the knowledge and geographical discrepancies in HIV/AIDS economic evaluation literature. Future research directions are also informed for advancing economic evaluation in HIV/AIDS research.

Health related quality of life of people receiving highly active antiretroviral therapy in Southwest Ethiopia

“…ART may indeed prolong life but may only do so at considerable cost to the QoL of PLWHA [ 17 ]. There is a geographical discrepancy in HIV/AIDS economic evaluation research [ 18 ]. The high cost of ART might reduce the adherence to treatment and worsen QoL [ 19 ].…”

Tıp Tarihi ile İlgili Çalışmaların Web of Science Veri Tabanı Üzerinden Bibliyometrik Analizi

“…Covid-19 ile ilgili çalışmaları gibi bibliyometrik analizler sağlık alanındaki güncel örneklerden birkaçıdır. 8,[10][11][12][13][14][15] Son yıllarda tıp tarihi ile ilgili çalışmaların da arttığı açıkça görülmektedir. Bu araştırma kapsamında taranan yayınlarda tıp tarihi literatürüne ait yayınlara özgü bibliyometrik analize rastlanmamıştır.…”

“…[4][5][6][7] Tıp tarihi alanındaki yayınların incelenebilmesi, literatüre en fazla katkı sunan yazar, kurum, üniversite, dergi gibi verilerin tespit edilebilmesi için sağlık ve tıp alanında kullanım popülerliği günden güne artan bibliyometrik analizler kullanılabilir. [8][9][10][11][12][13][14][15] Farklı birçok disiplinde kullanılan bibliyometrik analizlerin ortaya çıkış sürecine bakıldığında, ilk kez 1922 yılında E. Wyndham Hulme tarafından Cambridge Üniversitesi'nde "istatistiksel bibliyografya" terimi adı altında kullanıldığı görülmektedir. 16 Daha sonraları Raising'in bu terime 1962 yılında sağlık bilimlerinde alıntılama üzerine yaptığı bir makalesinde yer vermekte, Osareh ise bu yöntemin terim olarak tanımlanmadan önce kullanıldığını ifade etmektedir.…”

An Emerging Syndemic of Smoking and Cardiopulmonary Diseases in People Living with HIV in Africa

“…Moreover, the economic burden associated with comorbid conditions and the accompanying healthcare costs can threaten the financial stability of individuals, families, and communities and can cause significant stress for PWH. For example, for an individual living with HIV with two or more comorbidities, the costs for transportation to clinic visits and other medical costs are nearly triple that of those without HIV [ 106 ]. In LMICs, the economic burden of comorbidities impacts not only the patients, but also their family members and caretakers.…”